343 related articles for article (PubMed ID: 22357827)
1. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
Gostin LO
JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
[No Abstract] [Full Text] [Related]
2. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
3. Prescriptions, privacy, and the First Amendment.
Curfman GD; Morrissey S; Drazen JM
N Engl J Med; 2011 May; 364(21):2053-5. PubMed ID: 21524208
[No Abstract] [Full Text] [Related]
4. Higher First Amendment hurdles for public health regulation.
Outterson K
N Engl J Med; 2011 Aug; 365(7):e13. PubMed ID: 21812665
[No Abstract] [Full Text] [Related]
5. Restrictions on the use of prescribing data for drug promotion.
Mello MM; Messing NA
N Engl J Med; 2011 Sep; 365(13):1248-54. PubMed ID: 21812664
[No Abstract] [Full Text] [Related]
6. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: business practices. Issue brief.
Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
[No Abstract] [Full Text] [Related]
8. The future of off-label marketing regulations in the post-Sorrell era.
Iraggi J
Seton Hall Law Rev; 2013; 43(3):1137-63. PubMed ID: 23802338
[No Abstract] [Full Text] [Related]
9. Physician Exposure to Direct-to-Consumer Pharmaceutical Marketing: Potential for Creating Prescribing Bias.
Brown JL
Am J Med; 2017 Jun; 130(6):e247-e248. PubMed ID: 28089801
[No Abstract] [Full Text] [Related]
10. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
11. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
Steinman MA; Schillinger D
Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
[No Abstract] [Full Text] [Related]
12. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
Connors AL
Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
[No Abstract] [Full Text] [Related]
13. Financial incentives and the prescription of newer vaccines by doctors in India.
Lodha R; Bhargava A
Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
[No Abstract] [Full Text] [Related]
14. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
[TBL] [Abstract][Full Text] [Related]
15. Mixing Dinner and Drugs-Is It Ethically Contraindicated?
Essi DF
AMA J Ethics; 2015 Aug; 17(8):787-95. PubMed ID: 26270881
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
Jones TM
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-58. PubMed ID: 20213918
[No Abstract] [Full Text] [Related]
17. Health related claims, the market for information, and the first amendment.
Beales JH
Health Matrix Clevel; 2011; 21(1):7-30. PubMed ID: 21847896
[No Abstract] [Full Text] [Related]
18. When the First Amendment and public health collide: the Court's increasingly strict constitutional scrutiny of health regulations that restrict commercial speech.
Rauer S
Am J Law Med; 2012; 38(4):690-712. PubMed ID: 23356100
[No Abstract] [Full Text] [Related]
19. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
20. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late?
Kerwin R
J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
